UK markets closed

Tilray, Inc. (TLRY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.84+1.22 (+5.62%)
As of 12:57PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close21.63
Open21.73
Bid22.82 x 1000
Ask22.86 x 800
Day's range20.80 - 23.42
52-week range2.43 - 67.00
Volume11,615,958
Avg. volume40,180,436
Market cap3.924B
Beta (5Y monthly)2.86
PE ratio (TTM)N/A
EPS (TTM)-2.15
Earnings date17 Feb 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est19.32
  • Is Tilray Stock a Buy?
    Motley Fool

    Is Tilray Stock a Buy?

    Canadian weed giant Tilray (NASDAQ: TLRY) was on a tear for much of 2020. Investors have a lot to be thrilled about with Tilray, the most promising of which is its substantial international presence, which will become a game-changer as more countries legalize the recreational and medical use of cannabis. Let's investigate how Tilray can capitalize on marijuana's entry to the mainstream.

  • Why Aphria Rose 46.2% in February
    Motley Fool

    Why Aphria Rose 46.2% in February

    The Canadian pot stock rose amid a Reddit-fueled rally and positive earnings results from Tilray, which will merge with Aphria next quarter.

  • Why Tilray Stock Rose 35% in February
    Motley Fool

    Why Tilray Stock Rose 35% in February

    Tilray (NASDAQ: TLRY) stock outperformed a rising market last month. Shares soared 35% in February compared to a 2.6% gain in the S&P 500, according to data provided by S&P Global Market Intelligence. Tilray announced positive earnings results last month, with fourth-quarter sales increasing 26% as net loss improved to $3 million from $220 million a year earlier.